20 results on '"Anforth, Rachael"'
Search Results
2. Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study
3. Cutaneous toxicities of RAF inhibitors
4. Mechanisms of BRAFi-induced hyperproliferative cutaneous conditions
5. Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma
6. Dabrafenib-associated necrobiotic granulomatous reaction
7. Acneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinib
8. Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy
9. Mutant BRAF inhibitors: their cutaneous manifestations and the mechanisms leading to epidermal hyperproliferation and malignancy
10. Tinea hidden by a vemurafenib‐induced phototoxic reaction in a patient with metastatic melanoma taking dexamethasone
11. A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab
12. Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma
13. Acneiform eruption in a patient with metastatic melanoma after ceasing combination dabrafenib/trametinib therapy
14. Panniculitis in Patients Treated With BRAF Inhibitors
15. BRAF Inhibitor Induced Verrucal Keratosis
16. Acneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinib
17. Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking BRAF inhibitors
18. Systemic Retinoid Therapy for Chemoprevention of Nonmelanoma Skin Cancer in a Patient Treated With Vemurafenib
19. Cutaneous Side Effects of Single Versus Combined BRAF Inhibitors: A Comment to Erfan et al.
20. Investigating the impact of exercise on T and NK cells in skin cancer: a systematic review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.